Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-05

Clinical Trial Update: Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Apitox honeybee venom for osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apitox (honeybee venom)

Snippet

Sponsor: Apimeds, Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED